These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 16981554)
21. [Real and assumed potential savings in antihypertensive treatment. Right out of the magician's hat]. Anlauf M; Hense HW Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1557-9. PubMed ID: 12854069 [No Abstract] [Full Text] [Related]
22. Beta-blockers and the treatment of hypertension. Williams B J Hypertens; 2007 Jul; 25(7):1351-3. PubMed ID: 17563554 [No Abstract] [Full Text] [Related]
23. [Treating hypertension only in case of high risk? Evidence-based therapy with cost control]. Trenkwalder P MMW Fortschr Med; 2001 Feb; 143(7):45-6. PubMed ID: 11268751 [No Abstract] [Full Text] [Related]
26. Oil and water? Economic advantage and biomedical progress do not mix well in a government guidelines committee. Ménard J Am J Hypertens; 1994 Oct; 7(10 Pt 1):877-85. PubMed ID: 7826550 [TBL] [Abstract][Full Text] [Related]
27. [New therapeutic recommendations in the USA: blood pressure check ups of more persons--without proved benefits]. Werkö L Lakartidningen; 2003 Jun; 100(25):2237-8. PubMed ID: 12872516 [No Abstract] [Full Text] [Related]
28. [German Hypertension League update. What does the ALLHAT Study really mean?]. MMW Fortschr Med; 2003 Jun; 145(23):45-6. PubMed ID: 12854226 [No Abstract] [Full Text] [Related]
29. Antihypertensive pharmacotherapy in a developing economy: pattern, acquisition costs and conformity to international guidelines in a tertiary-care setting. Amira CO; Okubadejo NU J Hum Hypertens; 2006 Nov; 20(11):894-7. PubMed ID: 16915299 [No Abstract] [Full Text] [Related]
31. [Pharmacoeconomic assessment of antihypertensive therapy for patients of elderly and senile age in the hospital for veterans of war]. Hrinenko IuO; Kuprash LP Lik Sprava; 2010; (3-4):108-16. PubMed ID: 21265129 [TBL] [Abstract][Full Text] [Related]
34. [Fully possible to reduce the costs of hypertension treatment]. Wettermark B; Angman A; Hjemdahl P Lakartidningen; 2009 Jun 3-9; 106(23):1558-62. PubMed ID: 19583013 [No Abstract] [Full Text] [Related]
35. [Economy, costs and drug choices in cardiology. A reflection on the 2012 position paper of the Italian Society of Hypertension]. Camerini F; Palcic S G Ital Cardiol (Rome); 2013 Jun; 14(6):412-5. PubMed ID: 23748537 [No Abstract] [Full Text] [Related]
36. [The pharmaco-economics of the treatment of arterial hypertension: data and controversies]. Rorive G; Delporte JP Bull Mem Acad R Med Belg; 1998; 153(7-9):317-21; discussion 322-4. PubMed ID: 10100395 [TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of antihypertensive agents in patients with reduced left ventricular function. Arnold RJ; Kaniecki DJ; Frishman WH Pharmacotherapy; 1994; 14(2):178-84. PubMed ID: 8197036 [TBL] [Abstract][Full Text] [Related]
38. [Hypertension therapy--never without diuretics?]. Anlauf M MMW Fortschr Med; 2007 Nov; 149(46):31-3. PubMed ID: 18069189 [TBL] [Abstract][Full Text] [Related]
40. [Pharmacotherapy of hypertension. How much can safely be saved?]. Anlauf M MMW Fortschr Med; 2004 Apr; 146(15):57-8. PubMed ID: 15373022 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]